Scientific Opinion on the substantiation of a health claim related to barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 9, Issue 12, 2011, Pages

[No Author Info available]

Author keywords

Barley beta glucans; blood cholesterol; fibre; health claims; LDL cholesterol

Indexed keywords

EID: 85036542818     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2011.2470     Document Type: Article

References (33)

1. AbuMweis SS, Jew S and Ames NP, 2010. Beta-glucan from barley and its lipid lowering capacity: a meta-analysis of randomized, controlled trials. European Journal of Clinical Nutrition, 64, 1472–1480.
2. Behall KM, Scholfield DJ and Hallfrisch J, 2004a. Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. The American Journal of Clinical Nutrition, 80, 1185–1193.
3. Behall KM, Scholfield DJ and Hallfrisch J, 2004b. Lipids significantly reduced by diets containing barley in moderately hypercholesterolemic men. Journal of the American College of Nutrition, 23, 55–62.
4. Biörklund M, van Rees A, Mensink RP and Önning G, 2005. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomized dose-controlled trial. European Journal of Clinical Nutrition, 59, 1272–1281.
5. Bourdon I, Yokoyama W, Davis P, Hudson C, Backus R, Richter D, Knuckles B and Schneeman BO, 1999. Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with beta-glucan. The American Journal of Clinical Nutrition, 69, 55–63.
6. Denke MA, 2005. Diet, lifestyle, and nonstatin trials: review of time to benefit. American Journal of Cardiology, 96, 3–10.
7. Dongowski G, Huth M and Gebhardt E, 2006. Physiological effects of an extrudate from barley flour in humans. Deutsche Lebensmittel-Rundschau, 102, 141–149.
8. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2009. Scientific Opinion on the substantiation of health claims related to beta-glucans and maintenance of normal blood cholesterol concentrations (ID 754, 755, 757, 801, 1465, 2934) and maintenance or achievement of a normal body weight (ID 820, 823) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 7 (9): 1254, 18 pp.
9. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010. Scientific Opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal, 8 (12): 1885, 15 pp.
10. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011. Scientific Opinion on the substantiation of a health claim related to barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal, 9 (12): 2470, 13 pp.
11. FDA (US Food and Drug Administration), 2005. Food Labeling: Health Claims; Soluble Dietary Fiber From Certain Foods and Coronary Heart Disease. [Docket No. 2004P-0512]
12. FDA (US Food and Drug Administration), 2008. Food Labeling: Health Claims; Soluble Dietary Fiber From Certain Foods and Coronary Heart Disease. (Final Rule) [Docket No. FDA-2008-P-0090] (formerly Docket No. 2006P-0393)
13. Gordon DJ, 2000. Cholesterol lowering reduces mortality. The Statins. In: Cholesterol-Lowering Therapy. Evaluation of Clinical Trial Evidence. Ed Grundy SM. Marcel Dekker Inc., New York, USA, 299–311.
14. Ikegami S, Tomita M, Honda S, Yamaguchi M, Mizukawa, Suzuki Y, Ishii K, Ohsawa S, Kiyooka N, Higuchi M and Kobayashi S, 1996. Effect of boiled barley-rice-feeding in hypercholesterolemic and normolipemic subjects. Plant Foods for Human Nutrition, 49, 317–328.
15. Keenan JM, Goulson M, Shamliyan T, Knutson N, Kolberg L and Curry L, 2007. The effects of concentrated barley β-glucan on blood lipids and other CVD risk factors in a population of hypercholesterolaemic men and women. British Journal of Nutrition, 97, 1162–1168.
16. Keogh GF, Cooper GJ, Mulvey TB, McArdle BH, Coles GD, Monro JA and Poppitt SD, 2003. Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. The American Journal of Clinical Nutrition, 78, 711–718.
17. Li J, Kaneko T, Qin LQ, Wang J and Wang Y, 2003. Effects of barley intake on glucose tolerance, lipid metabolism, and bowel function in women. Nutrition, 19, 926–929.
18. Lupton JR, Robinson MC and Morin JL, 1994. Cholesterol-lowering effect of barley bran flour and oil. Journal of the American Dietetic Association, 94, 65–70.
19. McIntosh GH, Whyte J, MvArthur R and Nestel PJ, 1991. Barley and wheat foods: Influence on plasma cholesterol concentrations in hypercholesterolemic men. The American Journal of Clinical Nutrition, 53, 1205–1209.
20. Newman RK, Lewis SE, Newman CW, Boik RJ and Ramage RT, 1989. Hypocholesterolemic effect of barley foods on healthy men. Nutrition Reports International, 39, 749–760.
21. No authors listed, 2005, clinical study report, unpublished. Effects of boiled, flaked, milled barley powder product (Aktiv) on LDL-, HDL- and total cholesterol, triglycerides, glucose, insulin and HS-CRP levels in healthy hypercholesterolemic men and women. Centre for Human Studies of Foodstuffs (KPL), Uppsala.
22. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C and Brand RJ, 1998, erratum in 1999. Intensive lifestyle changes for reversal of coronary heart disease. Journal of the American Medical Association, 280, 2001–2007, erratum 281, 1380.
23. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M and Tsai J, 2005. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA, 294, 2437–2445.
24. Rondanelli M, Opizzi A, Monteferrario F, Klersy C, Cazzola R and Cestaro B, 2011. Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men. European Journal of Clinical Nutrition, 65, 864–871.
25. Shimizu C, Kihara M, Aoe S, Araki S, Ito K, Hayashi K, Watari J, Sakata Y and Ikegami S, 2008. Effect of high β-glucan barley on serum cholesterol concentrations and visceral fat area in Japanese men - a randomized, double-blinded, placebo-controlled trial. Plant Foods for Human Nutrition, 63, 21–25.
26. Smith KN, Queenan KM, Thomas W, Fulcher RG and Slavin JL, 2008. Physiological Effects of Concentrated Barley beta-Glucan in Mildly Hypercholesterolemic Adults. Journal of the American College of Nutrition, 27, 434–440.
27. Sundberg B, 2008. Cholesterol lowering effects of a barley fibre flake product. Agro Food Industry Hi-Tech, 19, 14–17.
28. Talati R, Baker WL, Pabilonia MS, White CM and Coleman CI, 2009. The Effects of Barley-Derived Soluble Fiber on Serum Lipids. Annals of Family Medicine, 7, 157–163.
29. Zhang JX, Lundin E, Andersson H, Bosaeus I, Dahlgren S, Hallmans G, Stenling R and Aman P, 1991. Brewer's Spent Grain, Serum Lipids and Fecal Sterol Excretion in Human Subjects with Ileostomies. The Journal of Nutrition, 121, 778–784.
30. Van Horn L, McCoin M, Kris-Etherton PM, Burke F, Carson JA, Champagne CM, Karmally W and Sikand G, 2008. The evidence for dietary prevention and treatment of cardiovascular disease. Journal of the American Dietetic Association, 108, 287–331.
31. WHO (World Health Organization), 2002a. Diet, nutrition and the prevention of chronic diseases. Report of a Joint WHO/FAO expert consultation, Geneva 28 January-1 February 2002. WHO Technical Report Series 916.
32. WHO (World Health Organisation), 2002b. The World Health Report 2002 - Reducing Risks, Promoting Healthy Life. Available from www.who.int/whr/2002/en/
33. Wood PJ, Beer MU and Butler G, 2000. Evaluation of role of concentration and molecular weight of oat β-glucan in determining effect of viscosity on plasma glucose and insulin following an oral glucose load. British Journal of Nutrition, 84, 19–23.